NM_001387283.1:c.2783T>C
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP2PP3_Strong
The NM_001387283.1(SMARCA4):c.2783T>C(p.Leu928Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 19 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 19 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 19 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 20 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 19 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 19 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.2783T>C | p.Leu928Pro | missense_variant | Exon 20 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.2195T>C | p.Leu732Pro | missense_variant | Exon 16 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.1427T>C | p.Leu476Pro | missense_variant | Exon 12 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.1508T>C | p.Leu503Pro | missense_variant | Exon 12 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.1268T>C | p.Leu423Pro | missense_variant | Exon 11 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.1136T>C | p.Leu379Pro | missense_variant | Exon 10 of 25 | ENSP00000494159.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Intellectual disability, autosomal dominant 16 Uncertain:1
- -
Rhabdoid tumor predisposition syndrome 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with SMARCA4-related disease. ClinVar contains an entry for this variant (Variation ID: 480625). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 928 of the SMARCA4 protein (p.Leu928Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.L928P variant (also known as c.2783T>C), located in coding exon 18 of the SMARCA4 gene, results from a T to C substitution at nucleotide position 2783. The leucine at codon 928 is replaced by proline, an amino acid with similar properties. This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6503 samples (13006 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.003% (greater than 30000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at